The total economic burden of coronary heart disease is $120.6 billion; of stroke is $48.9 billion.
---
Cutler, David M., Genia Long, Ernst R. Berndt, Jimmy Royer, Andree-Anne Fournier, Alicia Sasser, and Pierre Cremieux. "The Value Of Antihypertensive Drugs: A perspective on medical innovation". Health Affairs. Vol. 26, No. 1, pp. 97-110. [ Permalink ] |